Biologics Boom Drives Rapid Growth in Safety Testing Market
The global biologics safety testing market is experiencing significant growth as the biopharmaceutical industry continues to expand rapidly across vaccines, monoclonal antibodies, cell therapies, and gene therapies. The market is projected to grow from USD 5.57 billion in 2026 to USD 9.66 billion by 2031, registering a CAGR of 11.6% during the forecast period. The market was valued at...
0 Commentaires 0 Parts 182 Vue 0 Aperçu
Commandité